Post Content
The findings offer promising support for progressing ADPO-002NP treatment to first-in-human Phase I clinical trials. Adipo Therapeutics LLC, a late-stage preclinical biopharmaceutical company focused on developing treatments for obesity and related metabolic disorders, recently presented findings from two studies at The Obesity Society’s annual meeting in San Antonio. The studies were designed to evaluate the...
Tech giants and industrials lead as Tesla takes a dip The US stock market today offers a mixed bag of performances, with major tech players showing resilience, contrasted by notable losses in the auto manufacturing sector. Investors are navigating this patchwork of fortunes with keen attention to sector dynamics and broader market trends. 📈 Technology...
Glaucoma, the second leading cause of blindness globally, affects millions and is projected to reach 111.8 million cases by 2040. This progressive eye disorder results from fluid buildup, increasing intraocular pressure (IOP) and damaging the optic nerve. While treatments to lower IOP exist, they do not halt disease progression for...
A study published in Sexual Health has found a connection between involvement in sex work and symptoms of muscle dysmorphia among adolescents and young adults in Canada. Researchers found that individuals with a history of sex work reported higher levels of overall muscle dysmorphia symptoms, particularly in their drive for...
The universe is a fascinating tapestry of possibilities, woven from the threads of quantum mechanics. Among the most provocative ideas emerging from this field is the many-worlds interpretation (MWI), which suggests that countless parallel universes exist simultaneously, each representing a distinct reality. Despite its scientific roots, this theory has captivated...
